高级搜索
MDR1基因下调逆转人白血病阿霉素耐药细胞株K562/ADM的耐药性[J]. 肿瘤防治研究, 2010, 37(05): 515-518. DOI: 10.3971/j.issn.1000-8578.2010.05.007
引用本文: MDR1基因下调逆转人白血病阿霉素耐药细胞株K562/ADM的耐药性[J]. 肿瘤防治研究, 2010, 37(05): 515-518. DOI: 10.3971/j.issn.1000-8578.2010.05.007
Drug Resistance Reversal of Doxorubicin-resistant Human Leukemia Cell Line K562/ADM through Down-regulating MDR1 Gene[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 515-518. DOI: 10.3971/j.issn.1000-8578.2010.05.007
Citation: Drug Resistance Reversal of Doxorubicin-resistant Human Leukemia Cell Line K562/ADM through Down-regulating MDR1 Gene[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 515-518. DOI: 10.3971/j.issn.1000-8578.2010.05.007

MDR1基因下调逆转人白血病阿霉素耐药细胞株K562/ADM的耐药性

Drug Resistance Reversal of Doxorubicin-resistant Human Leukemia Cell Line K562/ADM through Down-regulating MDR1 Gene

  • 摘要: 目的:探讨RNA干扰(RNAi)人MDR1基因对人白血病阿霉素耐药细胞株K562/ADM耐药性的影响。方法:应用针对人MDR1基因的RNAi质粒pENTRTM/U6-MDR1转染人白血病阿霉素耐药细胞株K562/ADM和亲本细胞株K562,48 h后实时荧光定量PCR检测MDR1 mRNA表达,流式细胞术检测P-gp蛋白表达和P-gp功能,MTT法检测细胞对ADM的耐药性。结果:与未转染细胞相比,K562/ADM耐药细胞pENTRTM/U6-MDR1组的MDR1 mRNA和P-gp蛋白表达和功能均显著下降( P <0.05),对阿霉素的耐药性显著降低( P <0.05)。结论:MDR1基因下调可逆转人白血病阿霉素耐药细胞株对阿霉素的耐药性。

     

    Abstract: Objective To explore the effect of shRNA targeted to multidrug resistance gene 1(MDR1) by RNA interference (RNAi) on drug resistance of doxorubicin-resistant human leukemia cell line K562/ADM. Methods The RNAi plasmid of pENTRTM/U6-MDR1,targeting to human MDR1 gene, was transfected into doxorubicin-resistant human leukemia cell line K562/ADM and parental cell line K562.After 48h transfection, MDR1mRNA level was determined by real time RT-PCR. The expression and function of P-gp protein was analyzed by flow cytometry. Drug resistance of cells was detected by MTT assay. Results Compared with non-transfected cells, MDR1mRNA and expression levels and function ofP -gp protein in cells of pENTRTM/U6-MDR1 group decreased significantly( P <0.05).The resistance on doxorubicin was decreased drmatically( P <0.05). Conclusion The resistance on doxorubicin of human doxorubicin-resistant leukemia cells was reversed by MDR1 gene down-regulating.

     

/

返回文章
返回